Publication date: Oct 08, 2019
This post was originally published on this site Levels of certain trace metals are altered in the blood of people with Huntington’s disease, a new study found, suggesting that measuring and/or targeting these metals may be useful for studying, or perhaps treating, Huntington’s. Because of the effect trace metals can have on protein folding, researchers behind the new report wondered whether levels of any of these metals would be different in people with or without Huntington’s disease. Four of the essential trace metals were present at significantly higher levels in blood from people with Huntington’s than without; these were chromium (26 vs. 19 μg/L), iron (534,616 vs. 452,556 μg/L), selenium (138 vs. 101 μg/L) and zinc (5668 vs. 4640 μg/L). -We found abnormal concentrations of several metals in the blood of HD [Huntington’s disease] patients and propose that the metal profile may represent a useful tool for further insights of the pathology,” the researchers summarized, adding, -One therapeutic approach against HD or other neurodegenerative diseases could be targeting metals found in abnormal concentrations, since agents that target these metals may slow down or potentially reverse the course of the disease. ” The post Study Examines Levels of Trace Metals in Blood of Huntington’s Patients appeared first on Huntington’s Disease News.
|disease||MESH||amyotrophic lateral sclerosis|
|disease||DOID||amyotrophic lateral sclerosis|
- Emerging Therapeutics for Neurodegenerative Diseases Part II: Huntington’s Disease and Amyotrophic Lateral Sclerosis (HD & ALS)